AVH 2.35% 41.5¢ avita medical ltd

Patent extension, page-29

  1. 203 Posts.
    lightbulb Created with Sketch. 125
    It is almost a given, they are rarely denied a patent in these circumstances.

    In regards to 510K easier to post a link


    The costs etc to do with having a "generic" ReCell are many especially with a device like ReCell much more than a medicine which is a simple formula. Molds for the device which are expensive to design, make and the testing of the device working the same, it's not as bad as all th full clinical trials etc, but, it's just a lot more money, risk etc for something where the majority of the US market will be closed to them. I don't see it being worth it.
    Last edited by Tdeck1966: 21/04/19
watchlist Created with Sketch. Add AVH (ASX) to my watchlist
(20min delay)
Mkt cap ! $816.5M
Open High Low Value Volume
42.5¢ 42.5¢ 40.5¢ $352.4K 853.0K

Buyers (Bids)

No. Vol. Price($)
15 65189 41.0¢

Sellers (Offers)

Price($) Vol. No.
41.5¢ 22238 29
View Market Depth
Last update - 12.41pm 18/07/2019 (20 minute delay) ?
-0.010 ( 2.40 %)
Open High Low Volume
42.0¢ 42.0¢ 40.5¢ 90378
Last updated 12.49pm 18/07/2019 (live) ?
AVH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.